Chempolis Oy, a leader in biorefining technologies, has announced two major milestones. AM Green, a producer of green hydrogen and ammonia, will acquire a majority stake in Chempolis, including its subsidiary Chempolis India Private Limited. Additionally, Fortum Oyj will transfer its biobased solutions business, Bio2X, to Chempolis, following Fortum’s strategic shift in 2023.
AM Green focuses on producing green molecules to decarbonize hard-to-abate industries and aims to be a cost-competitive leader in this field. The venture is indirectly wholly owned by the founders of Greenko Group, one of India’s leading renewable energy companies and a major global player focusing on clean energy solutions.
The transfer of Fortum Bio2X marks the culmination of a long-term collaboration, integrating Bio2X’s expertise with Chempolis’ technologies. This move strengthens Chempolis’ strategic capabilities and market position. Chempolis has significant projects in India and Finland, including the world’s first bamboo-based biorefinery and a collaboration with NordFuel. The company also has promising projects in Asia, Europe, and the Americas.
Chempolis in brief
Chempolis’ formico®-technologies enable the production of high-quality products, such as bioethanol, biochemicals and sulfur-free lignin, sustainably out of lignocellulosic feedstocks. The process utilizes an extensive range of lignocellulosic biomasses in a flexible manner, with high material efficiency. The biorefining processes of Chempolis are designed to minimize negative environmental impacts and maximize social benefits globally. Chempolis’ services entail biorefinery project development, technology licensing, project and application development. The company also offers biorefinery piloting services.
Source: Chempolis